See more : Panion & Bf Biotech Inc. (1760.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Red Light Holland Corp. (TRIP.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Red Light Holland Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Kimco Realty Corporation (KIM) Income Statement Analysis – Financial Results
- Valencia Capital Inc. (VAL-P.V) Income Statement Analysis – Financial Results
- Seven Bank, Ltd. (SEBNF) Income Statement Analysis – Financial Results
- Costco Wholesale Corporation (COST.BA) Income Statement Analysis – Financial Results
- Hanwha Solutions Corporation (009835.KS) Income Statement Analysis – Financial Results
Red Light Holland Corp. (TRIP.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.redlighttruffles.com
About Red Light Holland Corp.
Red Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the recreational market in the Netherlands. It is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, cannabis bake house muffins, cookies, and cakes. The company sells its products under the iMicrodose and Maka brand name through 74 brick-and-mortar SmartShops, as well as through iMicrodose.nl and various other online stores across the Netherlands. Red Light Holland Corp. is based in Toronto, Ontario.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.75M | 3.95M | 2.33M | 110.96K | 0.00 | 10.84K | 40.82K | 187.50K | 378.40K | 727.85K | 209.37K | 799.36K |
| Cost of Revenue | 2.73M | 2.24M | 1.71M | 91.61K | 0.00 | 0.00 | 258.42K | 0.00 | 0.00 | 0.00 | 0.00 | 1.80M |
| Gross Profit | 2.02M | 1.71M | 617.68K | 19.35K | 0.00 | 10.84K | -217.60K | 187.50K | 378.40K | 727.85K | 209.37K | -1.00M |
| Gross Profit Ratio | 42.52% | 43.22% | 26.56% | 17.44% | 0.00% | 100.00% | -533.09% | 100.00% | 100.00% | 100.00% | 100.00% | -125.16% |
| Research & Development | 51.38K | 305.62K | 753.18K | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.89M | 5.65M | 8.42M | 4.61M | 325.17K | 190.89K | 318.60K | 300.71K | 291.45K | 411.40K | 665.05K | 1.50M |
| Selling & Marketing | 330.98K | 275.66K | 455.28K | 269.41K | 0.00 | 0.00 | 14.83K | 9.09K | 0.00 | 17.08K | 0.00 | 0.00 |
| SG&A | 7.22M | 5.93M | 8.42M | 4.61M | 325.17K | 190.89K | 333.43K | 309.80K | 291.45K | 428.48K | 665.05K | 1.50M |
| Other Expenses | -5.26M | -56.62K | 728.45K | 33.08K | -325.17K | -177.97K | -91.64K | -309.80K | -203.11K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.02M | 6.66M | 10.13M | 4.67M | 325.17K | 190.89K | 91.64K | 309.80K | 203.11K | 429.39K | 202.37K | 1.84M |
| Cost & Expenses | 10.94M | 8.90M | 11.83M | 4.76M | 325.17K | 190.89K | 350.20K | 323.47K | 225.16K | 429.39K | 202.37K | 3.64M |
| Interest Income | 531.18K | 208.85K | 63.55K | 17.04K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 259.37K | 55.93K | 50.43K | 10.72K | 0.00 | 0.00 | 134.00 | 13.67K | 22.04K | 39.94K | 63.67K | 200.53K |
| Depreciation & Amortization | 931.21K | 630.04K | 523.69K | 35.98K | 325.17K | 149.29K | 292.61K | 122.31K | -86.95K | -299.38K | 149.73K | 149.73K |
| EBITDA | -5.26M | -4.32M | -8.55M | -4.61M | 0.00 | 0.00 | -16.77K | -13.67K | 66.29K | 0.00 | -305.95K | -2.36M |
| EBITDA Ratio | -110.60% | -105.59% | -352.30% | -4,110.11% | 0.00% | -1,660.28% | -757.59% | 142.73% | 46.32% | -5.61% | -146.13% | -295.36% |
| Operating Income | -6.19M | -4.95M | -9.51M | -4.65M | -325.17K | -149.29K | -309.24K | -122.30K | 175.29K | 299.38K | -455.68K | -2.51M |
| Operating Income Ratio | -130.20% | -125.40% | -408.88% | -4,187.71% | 0.00% | -1,376.74% | -757.59% | -65.23% | 46.32% | 41.13% | -217.64% | -314.09% |
| Total Other Income/Expenses | -1.59M | -1.01M | -5.43M | 3.00M | 0.00 | 0.00 | 0.00 | 281.28K | 158.03K | -40.86K | 803.75K | -530.58K |
| Income Before Tax | -7.77M | -5.96M | -14.94M | -1.64M | -325.17K | -180.04K | -309.38K | 145.31K | 311.27K | 258.52K | 348.07K | -3.04M |
| Income Before Tax Ratio | -163.57% | -150.90% | -642.49% | -1,482.41% | 0.00% | -1,660.28% | -757.92% | 77.50% | 82.26% | 35.52% | 166.25% | -380.47% |
| Income Tax Expense | -59.19K | -159.50K | -246.40K | 43.81K | -325.17K | -180.04K | -16.90K | 253.94K | 202.28K | -80.80K | 0.00 | 0.00 |
| Net Income | -7.63M | -5.40M | -14.37M | -1.64M | -325.17K | -180.04K | -309.38K | 145.31K | 510.86K | 258.52K | 348.07K | -3.04M |
| Net Income Ratio | -160.51% | -136.67% | -617.78% | -1,482.41% | 0.00% | -1,660.28% | -757.92% | 77.50% | 135.01% | 35.52% | 166.25% | -380.47% |
| EPS | -0.02 | -0.01 | -0.04 | -0.01 | -0.38 | 0.00 | 0.00 | 0.01 | 0.07 | 0.85 | 1.57 | -15.35 |
| EPS Diluted | -0.02 | -0.01 | -0.04 | -0.01 | -0.38 | 0.00 | 0.00 | 0.01 | 0.07 | 0.85 | 1.57 | -15.35 |
| Weighted Avg Shares Out | 395.21M | 373.11M | 351.40M | 209.07M | 851.34K | 196.00M | 193.86M | 11.82M | 7.45M | 302.68K | 221.35K | 198.08K |
| Weighted Avg Shares Out (Dil) | 395.21M | 373.11M | 351.40M | 209.07M | 851.34K | 196.00M | 193.86M | 11.82M | 7.45M | 302.68K | 221.35K | 198.08K |
Source: https://incomestatements.info
Category: Stock Reports